China
Alphamab Oncology and CSPC Pharmaceutical's Phase III Trial of KN026 for HER2-Positive Breast Cancer Receives Approval from NMPA
Alphamab Oncology (stock code: 9966 HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (stock code: 1093.HK) jointly announced that an applicat...
October 17, 2024 | News
Innovent Biologics' Picankibart Achieves Primary Endpoint in Phase 2 Clinical Study for Ulcerative Colitis
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 17, 2024 | News
TenNor Therapeutics Secures Over 300 Million RMB in Series E Funding to Advance Novel Antibiotics for Drug-Resistant Infections
TenNor Therapeutics, a clinical stage company dedicated to developing new therapies to address unmet needs in infectious diseases, announced today the init...
October 17, 2024 | News
Dizal Receives Fourth Breakthrough Therapy Designation for Sunvozertinib in EGFR Exon20ins NSCLC
Fourth Breakthrough Therapy Designation for sunvozertinib in NSCLC with EGFR exon20ins Dizal (SSE:688192), a biopharmaceutical company committed to d...
October 14, 2024 | News
MediLink Therapeutics and Amgen Announce Global Clinical Collaboration to Evaluate Combination Therapy for Extensive-Stage Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, announced a global clinical trial collaboration and supply agreeme...
October 08, 2024 | News
Innovent Biologics and ASK Pharm Announce Strategic Partnership to Commercialize Limertinib for EGFR-Mutated Lung Cancer in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 08, 2024 | News
Ascentage Pharma’s APG-2449 Tyrosine Kinase Inhibitor Cleared for Two Registrational Phase III Studies in NSCLC Patients
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet med...
October 08, 2024 | News
Akeso's Cadonilimab Gains Approval for First-Line Treatment of Advanced Gastric Cancer in China
Akeso (9926. HK) announced that its internally developed PD-1/CTLA-4 bispecific antibody, cadonilimab, has received approval from the National Medical Prod...
October 01, 2024 | News
Doer Biologics Begins Phase 2 Study of First-in-Class Tri-Agonist DR10624 for Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...
October 01, 2024 | News
Sanyou Bio Expands Global Footprint with New 10,000-Square-Meter R&D Facility at Shanghai Headquarters
Sanyou Bio recently celebrated a prestigious move into its new 10,000-square-meter R&D building at Shanghai headquarters. This is not just a ...
September 30, 2024 | News
BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
As China continues to solidify its position as a global biotech hub, BIOCHINA 2025 promises to be a pivotal event for connecting exhibitors with top-tier C...
September 27, 2024 | Interview
Innovent Biologics' New Drug Application for Picankibart Accepted by China's NMPA for Treatment of Moderate to Severe Plaque Psoriasis
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
September 27, 2024 | News
Belief BioMed and AskBio Forge Strategic Collaboration to Advance Liver-Targeted Gene Therapies
Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach...
September 26, 2024 | News
Huawei Launches Medical Technology Digitalization 2.0 Solution to Elevate AI-Driven Healthcare
Huawei teamed up with partners to launch the Medical Technology Digitalization 2.0 Solution at the healthcare session named Enhancing Inclusivity to A...
September 24, 2024 | News
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
